Key Takeaways Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly worth…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2092473213-6be920f942a74eb2b7881e83c1461435.jpg?w=780&resize=780,470&ssl=1 "Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal")
Key Takeaways Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic. The sale is reportedly worth…
Read More »